Safety of Erenumab, Galcanezumab, and Fremanezumab Use During Pregnancy and Lactation
Researchers assessed safety reports on erenumab, galcanezumab, and fremanezumab, and conducted disproportionality analyses regarding suspected adverse drug reactions during pregnancy and lactation.